Table 1.
Clinical characteristics of the patients included in the study
| n = 40 | |
|---|---|
| Age (years) | 43 (31–56) |
| Female | 21 (52.5%) |
| BMI (kg/m2) | 20.5 (19.0–21.7) |
| Diabetes duration (years) | 2.6 (0.08–10.3) |
| HbA1c (%) | 8.2 (7.4–10.3) |
| (mmol/mol) | 66 (57–89) |
| Fasting serum C‐peptide (ng/mL) | 0.32 (0.00–0.94) |
| eGFR (mL/min/1.73 m2) | 111.1 (83.3–124.1) |
| Insulin treatment | |
| MDI/CSII | 32/8 |
| Total daily insulin dose per weight (units/day/kg) | 0.50 (0.33–0.75) |
| Basal/bolus ratio | 0.42 (0.30–0.61) |
Data are presented as n, n (%) or median (interquartile range). BMI, body mass index calculated by weight in kilograms divided by height in meters squared; CSII, continuous subcutaneous insulin infusion; eGFR, estimated glomerular filtration rate calculated using the following formula4: estimated GFR (mL/min/1.73 m2) = 194 × (serum creatinine level, mg/dL)−1.094 × (age, years)−0.287 (×0.739 if the patient was female); HbA1c, glycated hemoglobin; MDI, multiple daily injection.